These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9715008)

  • 1. Quick cancer test developed.
    Lund AE
    J Am Dent Assoc; 1998 Aug; 129(8):1080, 1082. PubMed ID: 9715008
    [No Abstract]   [Full Text] [Related]  

  • 2. Allopurinol-induced pyrimidinuria in cancer patients.
    Carducci MA; Choti M; Maestri NE; Brusilow SW
    In Vivo; 1998; 12(3):271-4. PubMed ID: 9706470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary oxipurinol-1-riboside excretion and allopurinol-induced oroticaciduria.
    Reiter S; Löffler W; Gröbner W; Zöllner N
    Adv Exp Med Biol; 1986; 195 Pt A():453-60. PubMed ID: 3728178
    [No Abstract]   [Full Text] [Related]  

  • 4. The allopurinol loading test in detecting obligate heterozygotes for OCT deficiency.
    Sebesta I; Krijt J; Fairbanks LD; Simmonds HA
    J Inherit Metab Dis; 1994; 17(1):133-4. PubMed ID: 8051924
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of dose and age on the response of the allopurinol test for ornithine carbamoyltransferase deficiency in control infants.
    Riudor E; Arranz JA; Rodés M; Rubio V; Sentís M; Burlina AB
    J Inherit Metab Dis; 2000 Nov; 23(7):662-8. PubMed ID: 11117427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allopurinol challenge test in children.
    Burlina AB; Ferrari V; Dionisi-Vici C; Bordugo A; Zacchello F; Tuchman M
    J Inherit Metab Dis; 1992; 15(5):707-12. PubMed ID: 1434508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The urinary excretion of orotic acid and orotidine, measured by an isotope dilution assay.
    Tax WJ; Veerkamp JH; Schretlen ED
    Clin Chim Acta; 1978 Dec; 90(3):217-23. PubMed ID: 365397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of orotic acid, orotidine and other pyrimidines in a patient with purine nucleoside phosphorylase deficiency.
    van Gennip AH; Grift J; de Bree PK; Zegers BJ; Stoop JW; Wadman SK
    Clin Chim Acta; 1979 May; 93(3):419-28. PubMed ID: 109238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary purines, pyrimidines and nucleosides in uridine-treated orotic aciduria.
    Mill GC
    Clin Chim Acta; 1988 Jun; 174(3):337-43. PubMed ID: 3390959
    [No Abstract]   [Full Text] [Related]  

  • 10. Purine and pyrimidine metabolism in hereditary oroticaciduria during a 15 year follow-up study.
    Webster DR; Simmonds HA; Potter CF; Becroft DM
    Adv Exp Med Biol; 1979; 122B():203-8. PubMed ID: 546145
    [No Abstract]   [Full Text] [Related]  

  • 11. The allopurinol loading test for identification of carriers for ornithine carbamoyl transferase deficiency: studies in a healthy control population and females at risk.
    Sebesta I; Fairbanks LD; Davies PM; Simmonds HA; Leonard JV
    Clin Chim Acta; 1994 Jan; 224(1):45-54. PubMed ID: 8174277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women.
    Hauser ER; Finkelstein JE; Valle D; Brusilow SW
    N Engl J Med; 1990 Jun; 322(23):1641-5. PubMed ID: 2342523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary Orotic Aciduria and the Excretion of Orotidine.
    Nyhan WL; Gangoiti JA
    Neuropediatrics; 2016 Dec; 47(6):408-409. PubMed ID: 27574833
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimization of allopurinol challenge: sample purification, protein intake control, and the use of orotidine response as a discriminative variable improve performance of the test for diagnosing ornithine carbamoyltransferase deficiency.
    Arranz JA; Riudor E; Rodés M; Roig M; Climent C; Rubio V; Sentís M; Burlina A
    Clin Chem; 1999 Jul; 45(7):995-1001. PubMed ID: 10388475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditions affecting the colorimetry of orotic acid and orotidine in urine.
    Harris ML; Oberholzer VG
    Clin Chem; 1980 Mar; 26(3):473-9. PubMed ID: 7363468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.
    Moyer JD; Handschumacher RE
    Cancer Res; 1979 Aug; 39(8):3089-94. PubMed ID: 455293
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of various purine and pyrimidine derivatives on human pyrimidine synthesis].
    Rauch-Janssen A; Gröbner W; Zöllner N
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():902-4. PubMed ID: 1029314
    [No Abstract]   [Full Text] [Related]  

  • 18. The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial disease.
    Bonham JR; Guthrie P; Downing M; Allen JC; Tanner MS; Sharrard M; Rittey C; Land JM; Fensom A; O'Neill D; Duley JA; Fairbanks LD
    J Inherit Metab Dis; 1999 Apr; 22(2):174-84. PubMed ID: 10234613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple method of measurement of orotic acid and orotidine in urine.
    Brusilow SW; Hauser E
    J Chromatogr; 1989 Sep; 493(2):388-91. PubMed ID: 2584305
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous determination of plasma and urinary uric acid, xanthine, hypoxanthine, allopurinol, oxipurinol, orotic acid, orotidine and creatinine by high-performance liquid chromatography.
    Miyazaki H; Matsunaga Y; Yoshida K; Arakawa S; Hashimoto M
    J Chromatogr; 1983 May; 274():75-85. PubMed ID: 6874855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.